Can a wearable glucose monitor keep hospital patients safer?

NCT ID NCT04230694

Completed Knowledge-focused Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested whether continuous glucose monitors (CGMs) can help manage blood sugar in hospitalized adults with diabetes. Forty patients wore a Dexcom G6 device during their hospital stay to track glucose levels. The goal was to see if CGM could reduce dangerous low or high blood sugar events compared to standard care. Results may show whether this technology is practical and effective for routine hospital use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Dexcom Generation 6 CGM device
What this could lead to: If successful, this could show that continuous glucose monitoring is a practical and effective way to manage blood sugar in hospitalized patients, reducing dangerous low and high blood sugar events.
What could go wrong: This is a small pilot study with only 40 participants, so results may not apply to all hospital settings. The device may not be as accurate in sicker patients or those on certain medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperglycemia hypoglycemia type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES DIABETES MELLITUS GLUCOSE, HIGH BLOOD GLUCOSE, LOW BLOOD

Contacts and locations

Locations

Baylor Scott & White Medical Center - Temple

Temple, Texas, 76508, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.